During the past decade, Ostalb-Klinikum Aalen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ostalb-Klinikum Aalen" #1 collaborator was "German Research Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ostalb-Klinikum Aalen" are "Lymphoma" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Ostalb-Klinikum Aalen" in a lesser frequency.

Most popular intervention types in "Ostalb-Klinikum Aalen" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lymphadenectomy (LNE)" (1 trials), "No Lymphadenectomy (LNE)" (1 trials), "cyclophosphamide" (1 trials), "doxorubicin hydrochloride" (1 trials) and "pegfilgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ostalb-Klinikum Aalen" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ostalb-Klinikum Aalen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ostalb-Klinikum Aalen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ostalb-Klinikum Aalen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".